ChronoScale Holdings Corp Amends Term Loan, Extends Maturity

What Happened
ChronoScale Holdings Corp (through its subsidiaries ChronoScale Intermediate, LLC (f/k/a Ekso Bionics Holdings, Inc.) and Ekso Bionics, Inc.) announced on September 16, 2026 (effective September 12, 2026) that it entered into a First Amendment to its Secured Promissory Note and Security Agreement with B. Riley Commercial Capital, LLC. The original secured term loan of up to $2.0 million remains outstanding at $2.0 million, and the amendment extends the loan’s maturity date and clarifies that a sale of the guarantor can be a permitted disposition.

Key Details

• Loan parties: ChronoScale Intermediate, LLC (Borrower) and Ekso Bionics, Inc. (Guarantor); Lender: B. Riley Commercial Capital, LLC.
• Original Term Loan: up to $2.0 million; outstanding balance as of the amendment: $2.0 million.
• Original maturity was the earlier of (i) 12 months after the September 12, 2025 Agreement or (ii) receipt of $2.4 million net from sale of Borrower equity; amendment extends the 12-month maturity date to November 12, 2026.
• The First Amendment provides that a sale of the Guarantor on the terms set forth in the amendment will be treated as a “Permitted Disposition.”
• All other material terms of the original Secured Promissory Note and Security Agreement remain unchanged.

Why It Matters
This amendment gives ChronoScale (and its subsidiaries) additional time—until November 12, 2026—to satisfy or refinance the $2.0 million term loan, which may reduce the short-term pressure to repay immediately. By explicitly allowing the sale of the guarantor (Ekso Bionics, Inc.) as a permitted disposition, the company preserves flexibility to pursue a sale transaction without automatically triggering a default under the loan agreement. Investors should note the company still carries the $2.0 million secured obligation and should watch future filings for any paydown, refinance, sale of the guarantor, or other changes to the loan terms.